Harm, ethics committees and the gene therapy death
Share this article
Click the icon of the social media platform on which you would like to share this article.
Email this article to a friend
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Other content recommended for you
- Gene therapy: targeting the myocardium
- The structure of ethics review: expert ethics committees and the challenge of voluntary research euthanasia
- Gene therapy for children with cystic fibrosis—who has the right to choose?
- Increased levels of osteopontin in sputum supernatant in severe refractory asthma
- Legitimate requests and indecent proposals: matters of justice in the ethical assessment of phase I trials involving competent patients
- Recent developments and current status of gene therapy using viral vectors in the United Kingdom
- Failure to inform public is undermining confidence in clinical trials
- Ornithine carbamoyltransferase deficiency
- An analysis of US fertility centre educational materials suggests that informed consent for preimplantation genetic diagnosis may be inadequate
- Perspectives of people with inherited retinal diseases on ocular gene therapy in Australia: protocol for a national survey